Viking Therapeutics has commenced a Phase I clinical trial of VK3019, a DACRA, which is under development as a potential...
Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients...
Haisco has signed an exclusive licensing agreement granting Nuvectis rights for two drug candidates in oncology and complement indications.The post...
Pfizer has reported topline data from the Phase III SigVie-002 study investigating sigvotatug vedotin in adults with previously treated, locally...
CereVasc has concluded patient enrolment in its STRIDE study, assessing the safety and effectiveness of the eShunt system for NPH.The...
Labcorp has announced the US availability of ColoSense, its FDA-approved RNA-based at-home screening test for colorectal cancer.The post Labcorp announces...
Medidata has announced the formation of its Academic Site Advisory Board to advance collaboration to enhance the progress of clinical...
Eli Lilly and Company has signed a research agreement with BioArctic to develop a potential treatment for neurodegenerative diseases.The post...
CureGene Pharmaceutical has dosed the first participant in its pivotal clinical trial of Evategrel, a next-generation antiplatelet therapy, in the...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.